Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,475.53
    -1,013.21 (-1.97%)
     
  • CMC Crypto 200

    1,320.95
    -75.59 (-5.41%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Global Organic Pharmaceutical Excipients Market Report 2021: Shifting Focus of Pharmaceutical Manufacturing to Emerging Countries

Dublin, May 06, 2021 (GLOBE NEWSWIRE) -- The "Global Organic Pharmaceutical Excipients Market (2020-2025) by Product, Function, Formulation, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

Growing pharmaceutical industry, increasing uptake of multifunctional excipients, and the availability of high quality raw materials and excipients are the key driving factors of the market. Furthermore, increasing chronic disease prevalence around the world enhances the demand for pharmaceutical products and thereby excipients.

Market Segmentation

By Geography, North America is projected to lead the market.

Recent Developments

  • 2020: Evonik launched RESOMER Precise platform of custom functional excipients to precisely control the release profile of parenteral drug products.

  • In April 2019, Colorcon, Inc. (US) signed an agreement with DuPont Nutrition and Biosciences (US) in order to enhance the current product portfolio of CR Alliance products.

  • In February 2019, Associated British Foods plc (UK) signed an agreement with Indchem International (India) under which, Indchem will distribute Associated British Food's functional lipid excipient product line in the Indian market.

Company Profiles

Some of the companies covered in this report are Air Liquide, Archer Daniels Midland Company, Ashland Global Holdings, Inc., Associated British Foods Plc, BASF SE, Colorcon, Croda International Plc, DFE Pharma, Dow Chemicals Corporation, DuPont de Nemours, Inc., Roquette Freres, WACKER Chemie AG, etc.

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Organic Pharmaceutical Excipients Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.

  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.

  • The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.

  • The report also contains the competitive analysis using the Competitive Quadrant, the analyst's proprietary competitive positioning tool.

ADVERTISEMENT

Key Topics Covered:

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary

4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Growth of pharmaceuticals market
4.2.1.2 Surge in the generics market
4.2.1.3 Increasing uptake of biopharmaceuticals
4.2.1.4 Rising adoption of orphan drugs
4.2.2 Restraints
4.2.2.1 Cost and time-intensive drug development process
4.2.2.2 Increasing regulatory stringency
4.2.3 Opportunities
4.2.3.1 Multifunctional excipients
4.2.3.2 Shifting focus of pharmaceutical manufacturing to emerging countries
4.2.3.3 Growth in the biosimilars market
4.2.4 Challenges
4.2.4.1 Safety and quality concerns
4.2.4.2 Changing trade policies
4.3 Trends

5 Market Analysis
5.1 Porter's Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis

6 Global Organic Pharmaceutical Excipients Market, By Product
6.1 Introduction
6.2 Organic Chemicals
6.3 Inorganic Chemicals
6.4 Other Devices

7 Global Organic Pharmaceutical Excipients Market, By Function
7.1 Introduction
7.2 Pharmaceutical Fillers
7.3 Binders
7.4 Coatings
7.5 Disintegrates
7.6 Preservatives
7.7 Lubricants & Glidants

8 Global Organic Pharmaceutical Excipients Market, By Formulation
8.1 Introduction
8.2 Oral
8.3 Topical
8.4 Parenteral
8.5 Advanced delivery system

9 Global Organic Pharmaceutical Excipients Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 South America
9.3.1 Brazil
9.3.2 Argentina
9.4 Europe
9.4.1 UK
9.4.2 France
9.4.3 Germany
9.4.4 Italy
9.4.5 Spain
9.4.6 Rest of Europe
9.5 Asia-Pacific
9.5.1 China
9.5.2 Japan
9.5.3 India
9.5.4 Indonesia
9.5.5 Malaysia
9.5.6 South Korea
9.5.7 Australia
9.5.8 Russia
9.5.9 Rest of APAC
9.6 Rest of the World
9.6.1 Qatar
9.6.2 Saudi Arabia
9.6.3 South Africa
9.6.4 United Arab Emirates
9.6.5 Latin America

10 Competitive Landscape
10.1 Competitive Quadrant
10.2 Market Share Analysis
10.3 Competitive Scenario
10.3.1 Mergers & Acquisitions
10.3.2 Agreement, Collaborations, & Partnerships
10.3.3 New Product Launches & Enhancements
10.3.4 Investments & Funding

11 Company Profiles

  • Air Liquide

  • Archer Daniels Midland Company

  • Ashland Global Holdings, Inc.

  • Associated British Foods Plc

  • BASF SE

  • Colorcon

  • Croda International Plc

  • DFE Pharma

  • Dow Chemicals Corporation

  • DuPont de Nemours, Inc.

  • Evonik Industries AG

  • Innophos Holdings

  • J.M. Huber Corporation

  • JRS Pharma

  • Kerry Group plc

  • Lubrizol Corporation

  • Merck Inc.

  • Merck Millipore

  • Roquette Freres

  • WACKER Chemie AG

For more information about this report visit https://www.researchandmarkets.com/r/d1wnrw

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900